Related Experiment Video
Updated: Jun 6, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
A new era in optimization of anti-infective therapy: Current challenges and priorities
Jordi Rello1, Virginie Prendki2, Grant W Waterer3
1Global Health eCORE, Vall d'Hebron Institute of Research, Barcelona, Spain; Centro de Investigacion Biomedica en Red, Instituto de Salud Carlos III, Madrid, Spain; IMAGINE, UR-UM 107, University of Montpellier, Division of Anaesthesia Critical Care, Pain and Emergency Medicine, Nîmes University Hospital, Nîmes, France; Medicine Department, Universitat Internacional de Catalunya, Barcelona, Spain.
No abstract available in PubMed .
More Related Videos
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Antimicrobial Effectiveness
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Antibiotic Selection
Endocarditis IV: Nursing Management

